COMMUNIQUÉS West-GlobeNewswire

Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain
02/10/2025
POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leader in non-opioid neuromodulation therapies for the treatment of chronic pain, today announced the publication of its landmark prospective, multi- [...]
PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of [...]
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
02/10/2025
Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA alignment on [...]
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2025 AANEM Annual Meeting
02/10/2025
Positive results from Phase 2 MaGic trial including additional analyses, and new preclinical data highlighting potential benefits of upstream inhibition, to be presented for claseprubart in generalized Myasthenia Gravis [...]
Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing
02/10/2025
PARAMUS, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, [...]
BioCardia Regains Compliance with Nasdaq Listing Requirements
02/10/2025
SUNNYVALE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has [...]
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
02/10/2025
ORANGE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2025 financial results on Thursday, Oct. 30, 2025, after market close. Following the release, [...]
Stride Autism Centers Opens New Bellevue, Nebraska Clinic, Expanding Access to Early Intervention ABA Therapy
02/10/2025
BELLEVUE, Neb., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, the Midwest’s leading provider of center-based Applied Behavior Analysis (ABA) therapy for young children with autism, is proud to announce the [...]
CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
02/10/2025
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that [...]
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
02/10/2025
PRINCETON, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today [...]
SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System
02/10/2025
Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 FORT LAUDERDALE, Fla., Oct. 02, [...]
Sienna Senior Living Completes Acquisition in Greater Toronto Area
02/10/2025
MARKHAM, Ontario, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its acquisition of Cawthra Gardens, a 192-bed Class A long- [...]
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization
02/10/2025
CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief [...]
AI Model Predicts Increase in Women Likely to Get Screening Mammograms
02/10/2025
GREENWICH, Conn., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cedar Gate Technologies (Cedar Gate), a leading value-based care technology and services company, today announced new data revealing that the number of women likely to [...]
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
02/10/2025
THE WOODLANDS, TX, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
The International Myeloma Foundation Welcomes Heather Cooper Ortner as New President & CEO
02/10/2025
STUDIO CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that Heather Cooper Ortner — President & CEO of Alzheimer’s Los Angeles, and former CEO of the Dr. [...]
Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
02/10/2025
FORT WORTH, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by [...]
Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Launches First Health Canada–Approved Product, Kicking Off Rebranded Pet Wellness Line
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) (“Ultrack” or the “Company”), through its wholly owned subsidiary Better Pets, is pleased to announce the upcoming launch of the Better Pets [...]
Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting
02/10/2025
Initial Phase 1 data suggest PRTH-101 contributes to disease control in recurrent/metastatic thymic epithelial carcinoma (TEC) with median progression-free survival (mPFS) of 7.9 months and 1 partial response (PR) [...]

Pages